drugset / Trial / NCT02397122

Platelet-rich Fibrin and Connective Tissue Graft in Recession Treatment

NCT02397122

Completed 40 enrolled Kırıkkale University
RandomizedParallel-groupSingle-blindTreatment

Summary

The aim of the trial is to evaluate the effectiveness of coronally advanced flap (CAF)+connective tissue graft(CTG)+platelet-rich fibrin(PRF) combination in Miller I and II recession treatment by comparing with CAF+CTG. 40 patients were surgically treated either with CAF+CTG+PRF (test group) or CAF+CTG (control group). Clinical parameters of plaque index (PI), gingival index (GI), vertical recession (VR), probing depth (PD), attachment level (AL), keratinized tissue width (KTW), horizontal recession (HR), MGJ localization (L-MGJ), tissue thickness (TT) were recorded at baseline, 3 months (PS1) and 6 months (PS2) post-surgery. Root coverage (RC), complete RC (CRC), attachment gain (AG), and keratinized tissue change (KTC) were also calculated.

Timeline

Start
2013-02
Primary completion
2013-12
Completion
2014-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Platelet Concentrate Other / unclassified

Indications